What is Artiva Biotherapeutics, Inc.'s investment proceeds?

Artiva Biotherapeutics, Inc. (ARTV) reported investment proceeds of $22M in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s investment proceeds changed year-over-year?

Artiva Biotherapeutics, Inc.'s investment proceeds decreased by 24.1% year-over-year, from $29M to $22M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Artiva Biotherapeutics, Inc. ARTV Investment Proceeds

Investment Proceeds at other companies

Allogene TherapeuticsALLO

$72.12M+27.6%

Immix Biopharma, Inc.IMMX

$3M—

ImmunityBio, Inc.IBRX

$79.38M+1,384%

Nektar TherapeuticsNKTR

$101.48M+46.4%

Avalo TherapeuticsAVTX

$25.51M—

Iovance Biotherapeutics, Inc.IOVA

$74M-38.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s investment proceeds?: Artiva Biotherapeutics, Inc. (ARTV) reported investment proceeds of $22M in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s investment proceeds changed year-over-year?: Artiva Biotherapeutics, Inc.'s investment proceeds decreased by 24.1% year-over-year, from $29M to $22M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.